Showing 8581-8590 of 19297 results for "".
- The Antiviral Tecovirimat Is Safe but Did Not Improve Clade I Mpox Resolution in Democratic Republic of the Congohttps://reachmd.com/news/the-antiviral-tecovirimat-is-safe-but-did-not-improve-clade-i-mpox-resolution-in-democratic-republic-of-the-congo/2467922/News ReleaseThursday, August 15, 2024The antiviral tecovirimat is safe but did not improve clade I mpox resolution in Democratic Republic of the Congo NIH-cosponsored study examined tecovirimat in mpox-endemic country. The
- Diabetes Management: Insights into Dietary Interventions with Protein Supplementshttps://reachmd.com/news/diabetes-management-insights-into-dietary-interventions-with-protein-supplements/2485084/A randomized crossover study found that a diabetes-specific protein supplement (DSPS) markedly reduced postprandial glycemic excursions in adults wit
- Discussions May Improve Adherence to Diabetes Medicationhttps://reachmd.com/news/discussions-may-improve-adherence-to-diabetes-medication/2462759/Credit: Pixabay/CC0 Public Domain Not taking medications exactly as prescribed is a major barrier to the treatment of diabet
- High Weekly Physical Activity Levels Linked to Lower Kidney Disease Risk in Diabetes + Overweight/Obesityhttps://reachmd.com/news/high-weekly-physical-activity-levels-linked-to-lower-kidney-disease-risk-in-diabetes-overweightobesity/2457093/Clocking up high weekly levels of moderate to vigorous intensity physical activity is linked to a lower risk of developing chronic kidney disease in overweight/obese people with type 2 diabetes, finds research published online in the
- Trends in Gestational Diabetes: Demographic Disparities and Public Health Implicationshttps://reachmd.com/news/trends-gestational-diabetes-disparities/2485132/A national analysis shows the incidence of gestational diabetes climbed from 58 to 79 cases per 1,000 births between 2016 and
- Real-World Insights on GLP-1 Receptor Agonists vs Metformin in Adolescent Diabetes Managementhttps://reachmd.com/news/real-world-insights-on-glp-1-receptor-agonists-vs-metformin-in-adolescent-diabetes-management/2484424/GLP-1 receptor agonists produced greater BMI reduction than metformin while maintaining comparable glycemic control in adolescents with type 2 diabetes — a result that could shift treatment choice for youth with obesity-associated disease. Metformin remains the conventiona
- FINE-ONE Trial Demonstrates Reduction in UACR with Finerenone in Type 1 Diabetes and CKDhttps://reachmd.com/news/finerenones-promise-in-treating-ckd-with-type-1-diabetes-insights-from-fine-one-phase-3/2484334/
- Trajectory of Type 1 Diabetes Risk Shifts After Age 10 Years Between At-risk Males and Females, Research Showshttps://reachmd.com/news/trajectory-of-type-1-diabetes-risk-shifts-after-age-10-years-between-at-risk-males-and-females-research-shows/2467583/by European Association for the Study of Obesity
- Dried Fruit Consumption Linked to Lower Type 2 Diabetes Risk, Study Surprisingly Findshttps://reachmd.com/news/dried-fruit-consumption-linked-to-lower-type-2-diabetes-risk-study-surprisingly-finds/2467488/
- Sugary Drinks, Fruit Juices Linked to Higher Risk of Developing Type 2 Diabetes Among Boyshttps://reachmd.com/news/sugary-drinks-fruit-juices-linked-to-higher-risk-of-developing-type-2-diabetes-among-boys/2462378/Credit: American Heart Association A small, long-term study of almost 500 children in Massachusetts has found that re